Rhelion Life Sciences Corp.
RHEL · CSE · CAD
CA$0.0250
+0.00 0.00%todayNot financial advice.
- Open
- 0.0250
- Day range
- 0.0250 - 0.0250
- 52-week range
- 0.0150 - 0.0500
- Volume
- 507.15K
- Market cap
- 10.79M
- P/E ratio
- —
- EPS
- -0.01
- Dividend yield
- 0.00%
- Beta
- -0.94
Performance
W
−16.67%
1M
−16.67%
3M
−16.67%
6M
−16.67%
YTD
0.00%
Y
−28.57%
5Y
−87.18%
All
−90.00%
In the news
Oct 8
Rhelion Subsidiary Licenses PEX010 to UCSF for Phase 2 Trial
Rhelion subsidiary Filament licenses PEX010 to UCSF for a Phase 2 trial treating methamphetamine use disorder in HIV patients.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/CSE-RHEL" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Rhelion Life Sciences Corp. (RHEL) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/CSE-RHEL">RHEL stock price</a> by FreeTheAI Stocks</p>